According to news reporting originating in Cambridge, United Kingdom, by NewsRx journalists, researchers stated “CD4+ T cells play key roles in orchestrating adaptive immune responses, and are a popular model for mammalian cell differentiation. While immune regulation would seem to require exactly adjusted mRNA and protein expression levels of key factors, there is little evidence […]
LMB In The News
Heptares and the MRC extend GPCR collaboration
“Heptares Therapeutics, the leading GPCR drug discovery company, has extended its collaboration with the MRC, in particular the research group led by Chris Tate, at the LMB.” More…
The LMB at 50
“LMB researcher Andy Holding tells us what it’s like to work at such an historic institution as it prepares to move to a new home.” More…
Portrait of Jason Chin
“Film profile of Jason Chin made by the European Patent Office” More…
Enamine, MRC LMB and IOCB announce collaboration to identify novel rhomboid protease inhibitors
“Enamine Ltd, a leading provider of screening compounds, chemical building blocks and discovery services, today announced that it has signed a collaboration agreement with the Medical Research Council Laboratory of Molecular Biology (MRC LMB), Cambridge, UK, and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (IOCB), Prague, […]
Halogen bonding helps design new drugs
“Scientists at the University of Tübingen, in cooperation with the MRC Laboratory of Molecular Biology in Cambridge / UK, have now demonstrated that halogen bonding can be used to identify potential drug candidates for cancer treatment. Dr. Rainer Wilcken and Prof. Frank Böckler in collaboration with Dr. Andreas Joerger and Prof. Sir Alan Fersht…” More…